nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP2C9—Rosuvastatin—atherosclerosis	0.0762	0.154	CbGbCtD
Bexarotene—CYP2C9—Simvastatin—atherosclerosis	0.0709	0.143	CbGbCtD
Bexarotene—CYP2C9—Pravastatin—atherosclerosis	0.0693	0.14	CbGbCtD
Bexarotene—CYP2C9—Lovastatin—atherosclerosis	0.0693	0.14	CbGbCtD
Bexarotene—CYP3A4—Rosuvastatin—atherosclerosis	0.0443	0.0893	CbGbCtD
Bexarotene—CYP3A4—Ezetimibe—atherosclerosis	0.0443	0.0893	CbGbCtD
Bexarotene—CYP3A4—Simvastatin—atherosclerosis	0.0412	0.083	CbGbCtD
Bexarotene—CYP3A4—Pravastatin—atherosclerosis	0.0403	0.0812	CbGbCtD
Bexarotene—CYP3A4—Lovastatin—atherosclerosis	0.0403	0.0812	CbGbCtD
Bexarotene—Flatulence—Ezetimibe—atherosclerosis	0.000565	0.00199	CcSEcCtD
Bexarotene—Pharyngitis—Pravastatin—atherosclerosis	0.000564	0.00199	CcSEcCtD
Bexarotene—Chills—Simvastatin—atherosclerosis	0.000564	0.00199	CcSEcCtD
Bexarotene—Muscle spasms—Lovastatin—atherosclerosis	0.000562	0.00198	CcSEcCtD
Bexarotene—Infection—Rosuvastatin—atherosclerosis	0.000559	0.00197	CcSEcCtD
Bexarotene—Alopecia—Simvastatin—atherosclerosis	0.000555	0.00196	CcSEcCtD
Bexarotene—Back pain—Ezetimibe—atherosclerosis	0.000555	0.00196	CcSEcCtD
Bexarotene—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000552	0.00195	CcSEcCtD
Bexarotene—Muscle spasms—Ezetimibe—atherosclerosis	0.000551	0.00195	CcSEcCtD
Bexarotene—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000551	0.00195	CcSEcCtD
Bexarotene—Erythema—Simvastatin—atherosclerosis	0.000547	0.00193	CcSEcCtD
Bexarotene—Ill-defined disorder—Lovastatin—atherosclerosis	0.000542	0.00191	CcSEcCtD
Bexarotene—Eye disorder—Niacin—atherosclerosis	0.000539	0.0019	CcSEcCtD
Bexarotene—Flatulence—Simvastatin—atherosclerosis	0.000539	0.0019	CcSEcCtD
Bexarotene—Tinnitus—Niacin—atherosclerosis	0.000538	0.0019	CcSEcCtD
Bexarotene—Dysgeusia—Simvastatin—atherosclerosis	0.000536	0.00189	CcSEcCtD
Bexarotene—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000532	0.00188	CcSEcCtD
Bexarotene—Anaemia—Ezetimibe—atherosclerosis	0.00053	0.00187	CcSEcCtD
Bexarotene—Tinnitus—Pravastatin—atherosclerosis	0.00053	0.00187	CcSEcCtD
Bexarotene—Malaise—Lovastatin—atherosclerosis	0.000527	0.00186	CcSEcCtD
Bexarotene—Cardiac disorder—Pravastatin—atherosclerosis	0.000527	0.00186	CcSEcCtD
Bexarotene—Muscle spasms—Simvastatin—atherosclerosis	0.000526	0.00186	CcSEcCtD
Bexarotene—Vertigo—Lovastatin—atherosclerosis	0.000525	0.00185	CcSEcCtD
Bexarotene—Angiopathy—Niacin—atherosclerosis	0.000523	0.00185	CcSEcCtD
Bexarotene—Leukopenia—Lovastatin—atherosclerosis	0.000523	0.00185	CcSEcCtD
Bexarotene—Chills—Niacin—atherosclerosis	0.000518	0.00183	CcSEcCtD
Bexarotene—Malaise—Ezetimibe—atherosclerosis	0.000517	0.00182	CcSEcCtD
Bexarotene—Arrhythmia—Niacin—atherosclerosis	0.000515	0.00182	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000513	0.00181	CcSEcCtD
Bexarotene—Alopecia—Niacin—atherosclerosis	0.00051	0.0018	CcSEcCtD
Bexarotene—Chills—Pravastatin—atherosclerosis	0.00051	0.0018	CcSEcCtD
Bexarotene—Insomnia—Rosuvastatin—atherosclerosis	0.000509	0.0018	CcSEcCtD
Bexarotene—Ill-defined disorder—Simvastatin—atherosclerosis	0.000507	0.00179	CcSEcCtD
Bexarotene—Arrhythmia—Pravastatin—atherosclerosis	0.000507	0.00179	CcSEcCtD
Bexarotene—Palpitations—Ezetimibe—atherosclerosis	0.000507	0.00179	CcSEcCtD
Bexarotene—Paraesthesia—Rosuvastatin—atherosclerosis	0.000506	0.00178	CcSEcCtD
Bexarotene—Anaemia—Simvastatin—atherosclerosis	0.000505	0.00178	CcSEcCtD
Bexarotene—Erythema—Niacin—atherosclerosis	0.000502	0.00177	CcSEcCtD
Bexarotene—Malnutrition—Niacin—atherosclerosis	0.000502	0.00177	CcSEcCtD
Bexarotene—Alopecia—Pravastatin—atherosclerosis	0.000502	0.00177	CcSEcCtD
Bexarotene—Cough—Ezetimibe—atherosclerosis	0.0005	0.00177	CcSEcCtD
Bexarotene—Chest pain—Lovastatin—atherosclerosis	0.000498	0.00176	CcSEcCtD
Bexarotene—Myalgia—Lovastatin—atherosclerosis	0.000498	0.00176	CcSEcCtD
Bexarotene—Arthralgia—Lovastatin—atherosclerosis	0.000498	0.00176	CcSEcCtD
Bexarotene—Anxiety—Lovastatin—atherosclerosis	0.000496	0.00175	CcSEcCtD
Bexarotene—Dyspepsia—Rosuvastatin—atherosclerosis	0.000496	0.00175	CcSEcCtD
Bexarotene—Hypertension—Ezetimibe—atherosclerosis	0.000495	0.00175	CcSEcCtD
Bexarotene—Flatulence—Niacin—atherosclerosis	0.000495	0.00175	CcSEcCtD
Bexarotene—Malaise—Simvastatin—atherosclerosis	0.000493	0.00174	CcSEcCtD
Bexarotene—Tension—Niacin—atherosclerosis	0.000493	0.00174	CcSEcCtD
Bexarotene—Discomfort—Lovastatin—atherosclerosis	0.000492	0.00174	CcSEcCtD
Bexarotene—Vertigo—Simvastatin—atherosclerosis	0.000491	0.00173	CcSEcCtD
Bexarotene—Leukopenia—Simvastatin—atherosclerosis	0.00049	0.00173	CcSEcCtD
Bexarotene—Arthralgia—Ezetimibe—atherosclerosis	0.000488	0.00172	CcSEcCtD
Bexarotene—Chest pain—Ezetimibe—atherosclerosis	0.000488	0.00172	CcSEcCtD
Bexarotene—Myalgia—Ezetimibe—atherosclerosis	0.000488	0.00172	CcSEcCtD
Bexarotene—Nervousness—Niacin—atherosclerosis	0.000488	0.00172	CcSEcCtD
Bexarotene—Flatulence—Pravastatin—atherosclerosis	0.000487	0.00172	CcSEcCtD
Bexarotene—Dry mouth—Lovastatin—atherosclerosis	0.000487	0.00172	CcSEcCtD
Bexarotene—Tension—Pravastatin—atherosclerosis	0.000485	0.00171	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000485	0.00171	CcSEcCtD
Bexarotene—Dysgeusia—Pravastatin—atherosclerosis	0.000484	0.00171	CcSEcCtD
Bexarotene—Muscle spasms—Niacin—atherosclerosis	0.000483	0.0017	CcSEcCtD
Bexarotene—Discomfort—Ezetimibe—atherosclerosis	0.000482	0.0017	CcSEcCtD
Bexarotene—Pain—Rosuvastatin—atherosclerosis	0.000481	0.0017	CcSEcCtD
Bexarotene—Constipation—Rosuvastatin—atherosclerosis	0.000481	0.0017	CcSEcCtD
Bexarotene—Confusional state—Lovastatin—atherosclerosis	0.000481	0.0017	CcSEcCtD
Bexarotene—Nervousness—Pravastatin—atherosclerosis	0.00048	0.00169	CcSEcCtD
Bexarotene—Dry mouth—Ezetimibe—atherosclerosis	0.000477	0.00168	CcSEcCtD
Bexarotene—Muscle spasms—Pravastatin—atherosclerosis	0.000475	0.00168	CcSEcCtD
Bexarotene—Infection—Lovastatin—atherosclerosis	0.000474	0.00167	CcSEcCtD
Bexarotene—Confusional state—Ezetimibe—atherosclerosis	0.000472	0.00167	CcSEcCtD
Bexarotene—Thrombocytopenia—Lovastatin—atherosclerosis	0.000467	0.00165	CcSEcCtD
Bexarotene—Chest pain—Simvastatin—atherosclerosis	0.000466	0.00164	CcSEcCtD
Bexarotene—Arthralgia—Simvastatin—atherosclerosis	0.000466	0.00164	CcSEcCtD
Bexarotene—Myalgia—Simvastatin—atherosclerosis	0.000466	0.00164	CcSEcCtD
Bexarotene—Infection—Ezetimibe—atherosclerosis	0.000465	0.00164	CcSEcCtD
Bexarotene—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000464	0.00164	CcSEcCtD
Bexarotene—Anxiety—Simvastatin—atherosclerosis	0.000464	0.00164	CcSEcCtD
Bexarotene—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00046	0.00162	CcSEcCtD
Bexarotene—Discomfort—Simvastatin—atherosclerosis	0.00046	0.00162	CcSEcCtD
Bexarotene—Nervous system disorder—Ezetimibe—atherosclerosis	0.000459	0.00162	CcSEcCtD
Bexarotene—Ill-defined disorder—Pravastatin—atherosclerosis	0.000459	0.00162	CcSEcCtD
Bexarotene—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000458	0.00162	CcSEcCtD
Bexarotene—Anaemia—Pravastatin—atherosclerosis	0.000457	0.00161	CcSEcCtD
Bexarotene—Anorexia—Lovastatin—atherosclerosis	0.000455	0.00161	CcSEcCtD
Bexarotene—Skin disorder—Ezetimibe—atherosclerosis	0.000455	0.0016	CcSEcCtD
Bexarotene—Vertigo—Niacin—atherosclerosis	0.000451	0.00159	CcSEcCtD
Bexarotene—Syncope—Niacin—atherosclerosis	0.00045	0.00159	CcSEcCtD
Bexarotene—Confusional state—Simvastatin—atherosclerosis	0.00045	0.00159	CcSEcCtD
Bexarotene—Leukopenia—Niacin—atherosclerosis	0.000449	0.00159	CcSEcCtD
Bexarotene—Oedema—Simvastatin—atherosclerosis	0.000446	0.00158	CcSEcCtD
Bexarotene—Malaise—Pravastatin—atherosclerosis	0.000446	0.00157	CcSEcCtD
Bexarotene—Abdominal pain—Rosuvastatin—atherosclerosis	0.000445	0.00157	CcSEcCtD
Bexarotene—Vertigo—Pravastatin—atherosclerosis	0.000444	0.00157	CcSEcCtD
Bexarotene—Palpitations—Niacin—atherosclerosis	0.000444	0.00157	CcSEcCtD
Bexarotene—Infection—Simvastatin—atherosclerosis	0.000443	0.00156	CcSEcCtD
Bexarotene—Leukopenia—Pravastatin—atherosclerosis	0.000443	0.00156	CcSEcCtD
Bexarotene—Loss of consciousness—Niacin—atherosclerosis	0.000441	0.00156	CcSEcCtD
Bexarotene—Cough—Niacin—atherosclerosis	0.000438	0.00155	CcSEcCtD
Bexarotene—Thrombocytopenia—Simvastatin—atherosclerosis	0.000437	0.00154	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000435	0.00153	CcSEcCtD
Bexarotene—Insomnia—Lovastatin—atherosclerosis	0.000432	0.00152	CcSEcCtD
Bexarotene—Cough—Pravastatin—atherosclerosis	0.000431	0.00152	CcSEcCtD
Bexarotene—Paraesthesia—Lovastatin—atherosclerosis	0.000428	0.00151	CcSEcCtD
Bexarotene—Arthralgia—Niacin—atherosclerosis	0.000428	0.00151	CcSEcCtD
Bexarotene—Myalgia—Niacin—atherosclerosis	0.000428	0.00151	CcSEcCtD
Bexarotene—Hypertension—Pravastatin—atherosclerosis	0.000427	0.00151	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000426	0.0015	CcSEcCtD
Bexarotene—Anorexia—Simvastatin—atherosclerosis	0.000425	0.0015	CcSEcCtD
Bexarotene—Dyspnoea—Lovastatin—atherosclerosis	0.000425	0.0015	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000425	0.0015	CcSEcCtD
Bexarotene—Insomnia—Ezetimibe—atherosclerosis	0.000423	0.00149	CcSEcCtD
Bexarotene—Myalgia—Pravastatin—atherosclerosis	0.000421	0.00149	CcSEcCtD
Bexarotene—Chest pain—Pravastatin—atherosclerosis	0.000421	0.00149	CcSEcCtD
Bexarotene—Arthralgia—Pravastatin—atherosclerosis	0.000421	0.00149	CcSEcCtD
Bexarotene—Paraesthesia—Ezetimibe—atherosclerosis	0.00042	0.00148	CcSEcCtD
Bexarotene—Dyspepsia—Lovastatin—atherosclerosis	0.00042	0.00148	CcSEcCtD
Bexarotene—Anxiety—Pravastatin—atherosclerosis	0.000419	0.00148	CcSEcCtD
Bexarotene—Dry mouth—Niacin—atherosclerosis	0.000418	0.00148	CcSEcCtD
Bexarotene—Dyspnoea—Ezetimibe—atherosclerosis	0.000417	0.00147	CcSEcCtD
Bexarotene—Discomfort—Pravastatin—atherosclerosis	0.000416	0.00147	CcSEcCtD
Bexarotene—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000415	0.00146	CcSEcCtD
Bexarotene—Decreased appetite—Lovastatin—atherosclerosis	0.000415	0.00146	CcSEcCtD
Bexarotene—Dyspepsia—Ezetimibe—atherosclerosis	0.000412	0.00145	CcSEcCtD
Bexarotene—Fatigue—Lovastatin—atherosclerosis	0.000411	0.00145	CcSEcCtD
Bexarotene—Oedema—Niacin—atherosclerosis	0.00041	0.00145	CcSEcCtD
Bexarotene—Constipation—Lovastatin—atherosclerosis	0.000408	0.00144	CcSEcCtD
Bexarotene—Pain—Lovastatin—atherosclerosis	0.000408	0.00144	CcSEcCtD
Bexarotene—Confusional state—Pravastatin—atherosclerosis	0.000407	0.00144	CcSEcCtD
Bexarotene—Decreased appetite—Ezetimibe—atherosclerosis	0.000407	0.00144	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000407	0.00143	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000404	0.00143	CcSEcCtD
Bexarotene—Asthenia—Rosuvastatin—atherosclerosis	0.000404	0.00143	CcSEcCtD
Bexarotene—Insomnia—Simvastatin—atherosclerosis	0.000404	0.00142	CcSEcCtD
Bexarotene—Oedema—Pravastatin—atherosclerosis	0.000404	0.00142	CcSEcCtD
Bexarotene—Fatigue—Ezetimibe—atherosclerosis	0.000404	0.00142	CcSEcCtD
Bexarotene—Shock—Niacin—atherosclerosis	0.000403	0.00142	CcSEcCtD
Bexarotene—Infection—Pravastatin—atherosclerosis	0.000401	0.00141	CcSEcCtD
Bexarotene—Paraesthesia—Simvastatin—atherosclerosis	0.000401	0.00141	CcSEcCtD
Bexarotene—Pain—Ezetimibe—atherosclerosis	0.0004	0.00141	CcSEcCtD
Bexarotene—Constipation—Ezetimibe—atherosclerosis	0.0004	0.00141	CcSEcCtD
Bexarotene—Tachycardia—Niacin—atherosclerosis	0.0004	0.00141	CcSEcCtD
Bexarotene—Pruritus—Rosuvastatin—atherosclerosis	0.000398	0.00141	CcSEcCtD
Bexarotene—Skin disorder—Niacin—atherosclerosis	0.000398	0.0014	CcSEcCtD
Bexarotene—Dyspnoea—Simvastatin—atherosclerosis	0.000398	0.0014	CcSEcCtD
Bexarotene—Hyperhidrosis—Niacin—atherosclerosis	0.000396	0.0014	CcSEcCtD
Bexarotene—Thrombocytopenia—Pravastatin—atherosclerosis	0.000395	0.00139	CcSEcCtD
Bexarotene—Feeling abnormal—Lovastatin—atherosclerosis	0.000393	0.00139	CcSEcCtD
Bexarotene—Dyspepsia—Simvastatin—atherosclerosis	0.000393	0.00139	CcSEcCtD
Bexarotene—Anorexia—Niacin—atherosclerosis	0.000391	0.00138	CcSEcCtD
Bexarotene—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00039	0.00138	CcSEcCtD
Bexarotene—Hyperhidrosis—Pravastatin—atherosclerosis	0.00039	0.00138	CcSEcCtD
Bexarotene—Decreased appetite—Simvastatin—atherosclerosis	0.000388	0.00137	CcSEcCtD
Bexarotene—Feeling abnormal—Ezetimibe—atherosclerosis	0.000386	0.00136	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000385	0.00136	CcSEcCtD
Bexarotene—Diarrhoea—Rosuvastatin—atherosclerosis	0.000385	0.00136	CcSEcCtD
Bexarotene—Fatigue—Simvastatin—atherosclerosis	0.000385	0.00136	CcSEcCtD
Bexarotene—Anorexia—Pravastatin—atherosclerosis	0.000385	0.00136	CcSEcCtD
Bexarotene—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000383	0.00135	CcSEcCtD
Bexarotene—Constipation—Simvastatin—atherosclerosis	0.000382	0.00135	CcSEcCtD
Bexarotene—Pain—Simvastatin—atherosclerosis	0.000382	0.00135	CcSEcCtD
Bexarotene—Body temperature increased—Lovastatin—atherosclerosis	0.000377	0.00133	CcSEcCtD
Bexarotene—Abdominal pain—Lovastatin—atherosclerosis	0.000377	0.00133	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000373	0.00132	CcSEcCtD
Bexarotene—Dizziness—Rosuvastatin—atherosclerosis	0.000372	0.00131	CcSEcCtD
Bexarotene—Insomnia—Niacin—atherosclerosis	0.000371	0.00131	CcSEcCtD
Bexarotene—Abdominal pain—Ezetimibe—atherosclerosis	0.00037	0.00131	CcSEcCtD
Bexarotene—Body temperature increased—Ezetimibe—atherosclerosis	0.00037	0.00131	CcSEcCtD
Bexarotene—Paraesthesia—Niacin—atherosclerosis	0.000368	0.0013	CcSEcCtD
Bexarotene—Feeling abnormal—Simvastatin—atherosclerosis	0.000368	0.0013	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000368	0.0013	CcSEcCtD
Bexarotene—Dyspnoea—Niacin—atherosclerosis	0.000365	0.00129	CcSEcCtD
Bexarotene—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000365	0.00129	CcSEcCtD
Bexarotene—Insomnia—Pravastatin—atherosclerosis	0.000365	0.00129	CcSEcCtD
Bexarotene—Somnolence—Niacin—atherosclerosis	0.000364	0.00129	CcSEcCtD
Bexarotene—Paraesthesia—Pravastatin—atherosclerosis	0.000362	0.00128	CcSEcCtD
Bexarotene—Dyspepsia—Niacin—atherosclerosis	0.000361	0.00127	CcSEcCtD
Bexarotene—Dyspnoea—Pravastatin—atherosclerosis	0.00036	0.00127	CcSEcCtD
Bexarotene—Decreased appetite—Niacin—atherosclerosis	0.000356	0.00126	CcSEcCtD
Bexarotene—Dyspepsia—Pravastatin—atherosclerosis	0.000355	0.00125	CcSEcCtD
Bexarotene—Rash—Rosuvastatin—atherosclerosis	0.000355	0.00125	CcSEcCtD
Bexarotene—Dermatitis—Rosuvastatin—atherosclerosis	0.000355	0.00125	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Niacin—atherosclerosis	0.000354	0.00125	CcSEcCtD
Bexarotene—Body temperature increased—Simvastatin—atherosclerosis	0.000353	0.00125	CcSEcCtD
Bexarotene—Abdominal pain—Simvastatin—atherosclerosis	0.000353	0.00125	CcSEcCtD
Bexarotene—Headache—Rosuvastatin—atherosclerosis	0.000353	0.00124	CcSEcCtD
Bexarotene—Hypersensitivity—Lovastatin—atherosclerosis	0.000352	0.00124	CcSEcCtD
Bexarotene—Decreased appetite—Pravastatin—atherosclerosis	0.000351	0.00124	CcSEcCtD
Bexarotene—Pain—Niacin—atherosclerosis	0.00035	0.00124	CcSEcCtD
Bexarotene—Fatigue—Pravastatin—atherosclerosis	0.000348	0.00123	CcSEcCtD
Bexarotene—Pain—Pravastatin—atherosclerosis	0.000345	0.00122	CcSEcCtD
Bexarotene—Constipation—Pravastatin—atherosclerosis	0.000345	0.00122	CcSEcCtD
Bexarotene—Hypersensitivity—Ezetimibe—atherosclerosis	0.000345	0.00122	CcSEcCtD
Bexarotene—Asthenia—Lovastatin—atherosclerosis	0.000342	0.00121	CcSEcCtD
Bexarotene—Pruritus—Lovastatin—atherosclerosis	0.000338	0.00119	CcSEcCtD
Bexarotene—Asthenia—Ezetimibe—atherosclerosis	0.000336	0.00118	CcSEcCtD
Bexarotene—Gastrointestinal pain—Niacin—atherosclerosis	0.000335	0.00118	CcSEcCtD
Bexarotene—Nausea—Rosuvastatin—atherosclerosis	0.000334	0.00118	CcSEcCtD
Bexarotene—Feeling abnormal—Pravastatin—atherosclerosis	0.000333	0.00117	CcSEcCtD
Bexarotene—Pruritus—Ezetimibe—atherosclerosis	0.000331	0.00117	CcSEcCtD
Bexarotene—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00033	0.00116	CcSEcCtD
Bexarotene—Hypersensitivity—Simvastatin—atherosclerosis	0.000329	0.00116	CcSEcCtD
Bexarotene—Diarrhoea—Lovastatin—atherosclerosis	0.000326	0.00115	CcSEcCtD
Bexarotene—Abdominal pain—Niacin—atherosclerosis	0.000324	0.00114	CcSEcCtD
Bexarotene—Body temperature increased—Niacin—atherosclerosis	0.000324	0.00114	CcSEcCtD
Bexarotene—Asthenia—Simvastatin—atherosclerosis	0.00032	0.00113	CcSEcCtD
Bexarotene—Diarrhoea—Ezetimibe—atherosclerosis	0.00032	0.00113	CcSEcCtD
Bexarotene—Abdominal pain—Pravastatin—atherosclerosis	0.000319	0.00113	CcSEcCtD
Bexarotene—Body temperature increased—Pravastatin—atherosclerosis	0.000319	0.00113	CcSEcCtD
Bexarotene—Pruritus—Simvastatin—atherosclerosis	0.000316	0.00111	CcSEcCtD
Bexarotene—Dizziness—Lovastatin—atherosclerosis	0.000316	0.00111	CcSEcCtD
Bexarotene—Dizziness—Ezetimibe—atherosclerosis	0.000309	0.00109	CcSEcCtD
Bexarotene—Diarrhoea—Simvastatin—atherosclerosis	0.000305	0.00108	CcSEcCtD
Bexarotene—Vomiting—Lovastatin—atherosclerosis	0.000303	0.00107	CcSEcCtD
Bexarotene—Hypersensitivity—Niacin—atherosclerosis	0.000302	0.00107	CcSEcCtD
Bexarotene—Rash—Lovastatin—atherosclerosis	0.000301	0.00106	CcSEcCtD
Bexarotene—Dermatitis—Lovastatin—atherosclerosis	0.000301	0.00106	CcSEcCtD
Bexarotene—Headache—Lovastatin—atherosclerosis	0.000299	0.00105	CcSEcCtD
Bexarotene—Vomiting—Ezetimibe—atherosclerosis	0.000298	0.00105	CcSEcCtD
Bexarotene—Hypersensitivity—Pravastatin—atherosclerosis	0.000297	0.00105	CcSEcCtD
Bexarotene—Dizziness—Simvastatin—atherosclerosis	0.000295	0.00104	CcSEcCtD
Bexarotene—Rash—Ezetimibe—atherosclerosis	0.000295	0.00104	CcSEcCtD
Bexarotene—Dermatitis—Ezetimibe—atherosclerosis	0.000295	0.00104	CcSEcCtD
Bexarotene—Asthenia—Niacin—atherosclerosis	0.000294	0.00104	CcSEcCtD
Bexarotene—Headache—Ezetimibe—atherosclerosis	0.000293	0.00103	CcSEcCtD
Bexarotene—Pruritus—Niacin—atherosclerosis	0.00029	0.00102	CcSEcCtD
Bexarotene—Asthenia—Pravastatin—atherosclerosis	0.00029	0.00102	CcSEcCtD
Bexarotene—Pruritus—Pravastatin—atherosclerosis	0.000285	0.00101	CcSEcCtD
Bexarotene—Vomiting—Simvastatin—atherosclerosis	0.000284	0.001	CcSEcCtD
Bexarotene—Nausea—Lovastatin—atherosclerosis	0.000283	0.001	CcSEcCtD
Bexarotene—Rash—Simvastatin—atherosclerosis	0.000281	0.000993	CcSEcCtD
Bexarotene—Dermatitis—Simvastatin—atherosclerosis	0.000281	0.000992	CcSEcCtD
Bexarotene—Diarrhoea—Niacin—atherosclerosis	0.00028	0.000989	CcSEcCtD
Bexarotene—Headache—Simvastatin—atherosclerosis	0.00028	0.000987	CcSEcCtD
Bexarotene—Nausea—Ezetimibe—atherosclerosis	0.000278	0.000981	CcSEcCtD
Bexarotene—Diarrhoea—Pravastatin—atherosclerosis	0.000276	0.000974	CcSEcCtD
Bexarotene—Dizziness—Niacin—atherosclerosis	0.000271	0.000956	CcSEcCtD
Bexarotene—Dizziness—Pravastatin—atherosclerosis	0.000267	0.000942	CcSEcCtD
Bexarotene—Nausea—Simvastatin—atherosclerosis	0.000265	0.000936	CcSEcCtD
Bexarotene—Vomiting—Niacin—atherosclerosis	0.000261	0.00092	CcSEcCtD
Bexarotene—Rash—Niacin—atherosclerosis	0.000258	0.000912	CcSEcCtD
Bexarotene—Dermatitis—Niacin—atherosclerosis	0.000258	0.000911	CcSEcCtD
Bexarotene—Headache—Niacin—atherosclerosis	0.000257	0.000906	CcSEcCtD
Bexarotene—Vomiting—Pravastatin—atherosclerosis	0.000257	0.000905	CcSEcCtD
Bexarotene—Rash—Pravastatin—atherosclerosis	0.000254	0.000898	CcSEcCtD
Bexarotene—Dermatitis—Pravastatin—atherosclerosis	0.000254	0.000897	CcSEcCtD
Bexarotene—Headache—Pravastatin—atherosclerosis	0.000253	0.000892	CcSEcCtD
Bexarotene—Nausea—Niacin—atherosclerosis	0.000243	0.000859	CcSEcCtD
Bexarotene—Nausea—Pravastatin—atherosclerosis	0.00024	0.000846	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	8.89e-05	0.000403	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—TNF—atherosclerosis	8.81e-05	0.0004	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—SIRT1—atherosclerosis	8.67e-05	0.000393	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—TGFB1—atherosclerosis	8.6e-05	0.00039	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ABCG1—atherosclerosis	8.46e-05	0.000384	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	8.33e-05	0.000378	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	8.19e-05	0.000371	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—SIRT1—atherosclerosis	8.15e-05	0.00037	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—LCAT—atherosclerosis	7.95e-05	0.000361	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—FABP4—atherosclerosis	7.95e-05	0.000361	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—PLG—atherosclerosis	7.86e-05	0.000357	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—LPL—atherosclerosis	7.81e-05	0.000354	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOA4—atherosclerosis	7.8e-05	0.000354	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP7A1—atherosclerosis	7.67e-05	0.000348	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	7.56e-05	0.000343	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—CD36—atherosclerosis	7.42e-05	0.000337	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—PPARA—atherosclerosis	7.33e-05	0.000333	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	7.31e-05	0.000332	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—HMOX1—atherosclerosis	7.25e-05	0.000329	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—PPARA—atherosclerosis	7.2e-05	0.000327	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	7.15e-05	0.000324	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—IL6—atherosclerosis	7.11e-05	0.000323	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	7.09e-05	0.000322	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP27A1—atherosclerosis	7.09e-05	0.000322	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	6.98e-05	0.000317	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—APOB—atherosclerosis	6.95e-05	0.000315	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	6.94e-05	0.000315	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—GSTM1—atherosclerosis	6.91e-05	0.000314	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PPARA—atherosclerosis	6.9e-05	0.000313	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—GSTM1—atherosclerosis	6.82e-05	0.000309	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	6.81e-05	0.000309	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—PPARA—atherosclerosis	6.77e-05	0.000307	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PLA2G2A—atherosclerosis	6.72e-05	0.000305	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOA2—atherosclerosis	6.72e-05	0.000305	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALOX5AP—atherosclerosis	6.72e-05	0.000305	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALOX15—atherosclerosis	6.72e-05	0.000305	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	6.67e-05	0.000302	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	6.67e-05	0.000302	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—ESR1—atherosclerosis	6.64e-05	0.000301	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ABCG5—atherosclerosis	6.64e-05	0.000301	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	6.63e-05	0.000301	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—LEP—atherosclerosis	6.55e-05	0.000297	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	6.54e-05	0.000297	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—ESR1—atherosclerosis	6.53e-05	0.000296	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	6.48e-05	0.000294	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	6.43e-05	0.000292	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—LPA—atherosclerosis	6.41e-05	0.000291	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—HSPA1B—atherosclerosis	6.25e-05	0.000283	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—BGN—atherosclerosis	6.21e-05	0.000282	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	6.16e-05	0.00028	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOA5—atherosclerosis	6.14e-05	0.000279	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—ESR1—atherosclerosis	6.14e-05	0.000278	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—PPARG—atherosclerosis	6.06e-05	0.000275	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	5.97e-05	0.000271	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—PPARG—atherosclerosis	5.95e-05	0.00027	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	5.94e-05	0.00027	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PLA2G1B—atherosclerosis	5.91e-05	0.000268	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—PPARA—atherosclerosis	5.86e-05	0.000266	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.85e-05	0.000265	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.79e-05	0.000263	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.78e-05	0.000262	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALOX5—atherosclerosis	5.71e-05	0.000259	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PPARG—atherosclerosis	5.7e-05	0.000259	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	5.63e-05	0.000256	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	5.63e-05	0.000256	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	5.63e-05	0.000256	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	5.63e-05	0.000256	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—PPARG—atherosclerosis	5.6e-05	0.000254	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—INS—atherosclerosis	5.59e-05	0.000254	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PARP1—atherosclerosis	5.57e-05	0.000253	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	5.56e-05	0.000252	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—APOA1—atherosclerosis	5.5e-05	0.000249	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—SERPINE1—atherosclerosis	5.46e-05	0.000248	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	5.37e-05	0.000244	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—SERPINE1—atherosclerosis	5.36e-05	0.000243	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.28e-05	0.000239	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—ESR2—atherosclerosis	5.27e-05	0.000239	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP2—atherosclerosis	5.24e-05	0.000238	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	5.15e-05	0.000234	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NAMPT—atherosclerosis	5.12e-05	0.000232	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.09e-05	0.000231	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—LIPC—atherosclerosis	5.09e-05	0.000231	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOC3—atherosclerosis	5.06e-05	0.00023	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—SERPINE1—atherosclerosis	5.04e-05	0.000229	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—LDLR—atherosclerosis	5.03e-05	0.000228	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	4.96e-05	0.000225	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CETP—atherosclerosis	4.91e-05	0.000223	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	4.9e-05	0.000222	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	4.82e-05	0.000219	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	4.79e-05	0.000217	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—SCARB1—atherosclerosis	4.7e-05	0.000213	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLTP—atherosclerosis	4.61e-05	0.000209	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.58e-05	0.000208	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	4.56e-05	0.000207	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	4.49e-05	0.000204	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—HMGCR—atherosclerosis	4.44e-05	0.000202	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—ALB—atherosclerosis	4.35e-05	0.000198	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	4.27e-05	0.000194	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—SIRT1—atherosclerosis	4.25e-05	0.000193	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	4.24e-05	0.000192	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	4.22e-05	0.000191	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	4.12e-05	0.000187	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.01e-05	0.000182	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ABCG8—atherosclerosis	3.99e-05	0.000181	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LTA4H—atherosclerosis	3.99e-05	0.000181	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ABCA1—atherosclerosis	3.96e-05	0.00018	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	3.94e-05	0.000179	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP9—atherosclerosis	3.94e-05	0.000179	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—NFKB1—atherosclerosis	3.89e-05	0.000177	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	3.72e-05	0.000169	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—VEGFA—atherosclerosis	3.53e-05	0.00016	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPARA—atherosclerosis	3.53e-05	0.00016	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—STAT3—atherosclerosis	3.5e-05	0.000159	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—MAPK3—atherosclerosis	3.49e-05	0.000158	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—HMOX1—atherosclerosis	3.4e-05	0.000154	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MAPK3—atherosclerosis	3.34e-05	0.000152	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	3.32e-05	0.000151	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—MAPK3—atherosclerosis	3.28e-05	0.000149	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOB—atherosclerosis	3.25e-05	0.000148	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TGFB1—atherosclerosis	3.24e-05	0.000147	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	3.23e-05	0.000147	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—ESR1—atherosclerosis	3.2e-05	0.000145	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTM1—atherosclerosis	3.17e-05	0.000144	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ABCG1—atherosclerosis	3.16e-05	0.000143	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—LPL—atherosclerosis	3.11e-05	0.000141	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLTP—atherosclerosis	3.04e-05	0.000138	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GPX1—atherosclerosis	3.03e-05	0.000138	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TNF—atherosclerosis	3.03e-05	0.000137	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—FABP4—atherosclerosis	2.97e-05	0.000135	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LCAT—atherosclerosis	2.97e-05	0.000135	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CD36—atherosclerosis	2.95e-05	0.000134	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPARG—atherosclerosis	2.92e-05	0.000132	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOA4—atherosclerosis	2.91e-05	0.000132	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP7A1—atherosclerosis	2.86e-05	0.00013	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—MTHFR—atherosclerosis	2.8e-05	0.000127	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPARA—atherosclerosis	2.74e-05	0.000125	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.73e-05	0.000124	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AGT—atherosclerosis	2.66e-05	0.000121	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP27A1—atherosclerosis	2.65e-05	0.00012	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.63e-05	0.00012	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.63e-05	0.00012	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—SERPINE1—atherosclerosis	2.63e-05	0.000119	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.6e-05	0.000118	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOE—atherosclerosis	2.6e-05	0.000118	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CAV1—atherosclerosis	2.58e-05	0.000117	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOA1—atherosclerosis	2.57e-05	0.000117	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.54e-05	0.000115	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	2.51e-05	0.000114	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	2.51e-05	0.000114	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOA2—atherosclerosis	2.51e-05	0.000114	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALOX15—atherosclerosis	2.51e-05	0.000114	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ABCG5—atherosclerosis	2.48e-05	0.000112	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.47e-05	0.000112	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IL6—atherosclerosis	2.44e-05	0.000111	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LPA—atherosclerosis	2.39e-05	0.000109	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—AKT1—atherosclerosis	2.35e-05	0.000107	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CG—atherosclerosis	2.35e-05	0.000107	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—BGN—atherosclerosis	2.32e-05	0.000105	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.3e-05	0.000104	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOA5—atherosclerosis	2.29e-05	0.000104	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPARG—atherosclerosis	2.27e-05	0.000103	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—AKT1—atherosclerosis	2.25e-05	0.000102	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.23e-05	0.000101	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—INS—atherosclerosis	2.22e-05	0.000101	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—AKT1—atherosclerosis	2.21e-05	0.0001	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	2.21e-05	0.0001	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.18e-05	9.91e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.16e-05	9.81e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.16e-05	9.79e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALOX5—atherosclerosis	2.13e-05	9.68e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ABCG1—atherosclerosis	2.08e-05	9.45e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALB—atherosclerosis	2.04e-05	9.26e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.97e-05	8.94e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LCAT—atherosclerosis	1.96e-05	8.88e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—FABP4—atherosclerosis	1.96e-05	8.88e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—NOS3—atherosclerosis	1.95e-05	8.85e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOA4—atherosclerosis	1.92e-05	8.72e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.91e-05	8.68e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.9e-05	8.63e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LIPC—atherosclerosis	1.9e-05	8.62e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOC3—atherosclerosis	1.89e-05	8.57e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.89e-05	8.57e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LDLR—atherosclerosis	1.88e-05	8.52e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CETP—atherosclerosis	1.83e-05	8.32e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTGS2—atherosclerosis	1.78e-05	8.1e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.76e-05	7.97e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.74e-05	7.92e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—MAPK3—atherosclerosis	1.71e-05	7.76e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.71e-05	7.76e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.66e-05	7.53e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.65e-05	7.51e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.65e-05	7.51e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.65e-05	7.51e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOA2—atherosclerosis	1.65e-05	7.51e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.63e-05	7.41e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LPA—atherosclerosis	1.58e-05	7.16e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—BGN—atherosclerosis	1.53e-05	6.93e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOA5—atherosclerosis	1.51e-05	6.86e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.5e-05	6.79e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.48e-05	6.71e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.46e-05	6.61e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.41e-05	6.38e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.27e-05	5.75e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.26e-05	5.72e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LIPC—atherosclerosis	1.25e-05	5.69e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOC3—atherosclerosis	1.25e-05	5.65e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LDLR—atherosclerosis	1.24e-05	5.62e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOB—atherosclerosis	1.21e-05	5.51e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CETP—atherosclerosis	1.21e-05	5.49e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.18e-05	5.36e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LPL—atherosclerosis	1.16e-05	5.26e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.16e-05	5.26e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—AKT1—atherosclerosis	1.15e-05	5.23e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GPX1—atherosclerosis	1.13e-05	5.13e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CD36—atherosclerosis	1.1e-05	5e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.09e-05	4.96e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—MTHFR—atherosclerosis	1.04e-05	4.74e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPARA—atherosclerosis	1.02e-05	4.65e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AGT—atherosclerosis	9.92e-06	4.5e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ABCA1—atherosclerosis	9.75e-06	4.42e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOE—atherosclerosis	9.72e-06	4.41e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CAV1—atherosclerosis	9.63e-06	4.37e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOA1—atherosclerosis	9.61e-06	4.36e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AKT1—atherosclerosis	8.97e-06	4.07e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CG—atherosclerosis	8.77e-06	3.98e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPARG—atherosclerosis	8.47e-06	3.84e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HMOX1—atherosclerosis	8.36e-06	3.8e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—INS—atherosclerosis	8.31e-06	3.77e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOB—atherosclerosis	8.01e-06	3.64e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTM1—atherosclerosis	7.79e-06	3.54e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LPL—atherosclerosis	7.65e-06	3.47e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALB—atherosclerosis	7.62e-06	3.46e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GPX1—atherosclerosis	7.46e-06	3.39e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—NOS3—atherosclerosis	7.28e-06	3.31e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CD36—atherosclerosis	7.27e-06	3.3e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—MTHFR—atherosclerosis	6.89e-06	3.13e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPARA—atherosclerosis	6.76e-06	3.07e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGS2—atherosclerosis	6.66e-06	3.02e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AGT—atherosclerosis	6.54e-06	2.97e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOE—atherosclerosis	6.41e-06	2.91e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CAV1—atherosclerosis	6.35e-06	2.88e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOA1—atherosclerosis	6.34e-06	2.88e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CG—atherosclerosis	5.79e-06	2.63e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPARG—atherosclerosis	5.59e-06	2.53e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—INS—atherosclerosis	5.48e-06	2.49e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALB—atherosclerosis	5.02e-06	2.28e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—NOS3—atherosclerosis	4.8e-06	2.18e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGS2—atherosclerosis	4.39e-06	1.99e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AKT1—atherosclerosis	3.35e-06	1.52e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AKT1—atherosclerosis	2.21e-06	1e-05	CbGpPWpGaD
